Time Finance Regulatory News (TIME)

8 Feb 2007 07:02

Timestrip PLC08 February 2007 Timestrip plc Technology Update - iStrip Timestrip plc (the 'Company')(AIM: TIME), the developer and manufacturer of unique label technologies, is pleased to announce an update on progress with iStrip, the patent pending label that is capable of recording whether temperature sensitive products, such as vaccines, have been accidentally frozen during transport or storage. Further to the launch of iStrip in September last year, the Company is now working with PATH, the Seattle based international non-profit organisation that improves the health of people around the world by advancing technologies, strengthening systems, and encouraging healthy behaviour. One of PATH's active programmes seeks to identify the incidence of accidental freezing in vaccines, and the Company is delighted to be working with PATH in order to evaluate the benefits and opportunities for the iStrip technology in this field. PATH is evaluating the technology and giving feedback and inputs to the Company on the design, and its appropriateness for developing country use. Reuben Isbitsky, Joint CEO, Timestrip Plc: "PATH is at the forefront of validating and promoting technologies which deliver improvements in health, so this represents an important link for the Company to the field of global health." Enquiries: Paul Freedman/Reuben Isbitsky, Joint CEOs, Timestrip plc 01462 440 700Shane Dolan, Biddicks 020 7448 1000Fergus Marcroft, Evolution Securities 020 7071 4300 About PATH (www.path.org)PATH is an international, nonprofit organization that creates sustainable, culturally relevant solutions, enabling communities worldwide to break longstanding cycles of poor health. By collaborating with diverse public- and private-sector partners, PATH helps provide appropriate health technologies and vital strategies that change the way people think and act. This information is provided by RNS The company news service from the London Stock Exchange